These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4450660)

  • 41. The effect of ecarin- defibrinating enzyme isolated from Echis carinatus - on experimental arterial thrombosis.
    Kornalík F; Hladovec J
    Thromb Res; 1975 Oct; 7(4):611-21. PubMed ID: 1198548
    [No Abstract]   [Full Text] [Related]  

  • 42. [Drug therapy of peripheral arterial occlusive disease].
    Mahler F
    Schweiz Med Wochenschr; 1981 May; 111(18):637-40. PubMed ID: 7244587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Venom of the Brown Treesnake, Boiga irregularis: ontogenetic shifts and taxa-specific toxicity.
    Mackessy SP; Sixberry NM; Heyborne WH; Fritts T
    Toxicon; 2006 Apr; 47(5):537-48. PubMed ID: 16545413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom.
    Waghmare A; Deopurkar RL; Salvi N; Khadilkar M; Kalolikar M; Gade SK
    Vaccine; 2009 Feb; 27(7):1067-72. PubMed ID: 19100805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Venom as a source of useful biologically active molecules.
    Bailey P; Wilce J
    Emerg Med (Fremantle); 2001 Mar; 13(1):28-36. PubMed ID: 11476408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Taking the sting out of pain.
    Peplow M
    Sci Am; 2014 Dec; 311(6):66. PubMed ID: 25518630
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term results after defibrinogenation by Arwin in chronic occlusive arterial disease.
    Staiger J; Konrad-Graf S; Keil G
    Bibl Haematol; 1981; (47):252-7. PubMed ID: 7337665
    [No Abstract]   [Full Text] [Related]  

  • 48. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Conservative therapy of chronic arterial occlusions in the extremities].
    Nobbe F
    Verh Dtsch Ges Inn Med; 1972; 78():520-33. PubMed ID: 4665689
    [No Abstract]   [Full Text] [Related]  

  • 50. Randomised control trial on the effective dose of anti-snake venom in cases of snake bite with systemic envenomation.
    Seth AK; Varma PP; Pakhetra R
    J Assoc Physicians India; 2000 Jul; 48(7):756. PubMed ID: 11273522
    [No Abstract]   [Full Text] [Related]  

  • 51. [Acetylcholinesterase from snake venoms].
    Cousin X; Bon C
    C R Seances Soc Biol Fil; 1997; 191(3):381-400. PubMed ID: 9295965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of snake venom proteins in medicine].
    Stocker K
    Schweiz Med Wochenschr; 1999 Feb; 129(6):205-16. PubMed ID: 10093879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Case of poisoning with snake venom during its sucking off from the victim's wound].
    Pidluskaia MN; Berezhnitskiĭ MN
    Vrach Delo; 1974 Aug; 0(8):121-2. PubMed ID: 4408752
    [No Abstract]   [Full Text] [Related]  

  • 54. Acetylcholinesterase from snake venom as a model for its nerve and muscle counterpart.
    Cousin X; Bon C
    J Nat Toxins; 1999 Jun; 8(2):285-94. PubMed ID: 10410339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cross reactivity between venomous, mildly venomous, and non-venomous snake venoms with the Commonwealth Serum Laboratories Venom Detection Kit.
    Jelinek GA; Tweed C; Lynch D; Celenza T; Bush B; Michalopoulos N
    Emerg Med Australas; 2004; 16(5-6):459-64. PubMed ID: 15537410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comments on "suicide by injection of snake venom".
    Sutherland SK; Coulter AR
    Forensic Sci; 1978; 11(3):241-3. PubMed ID: 680615
    [No Abstract]   [Full Text] [Related]  

  • 57. Venoms, copper, and zinc in the treatment of arthritis.
    Caldwell JR
    Rheum Dis Clin North Am; 1999 Nov; 25(4):919-28, viiiix. PubMed ID: 10573766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dye ligand chromatography: a method for the simple separation of some enzymes of snake venom.
    Ferlan I; Ferlan A; Russell FE
    Proc West Pharmacol Soc; 1982; 25():205-9. PubMed ID: 7122494
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 60. Peptide fingerprinting of snake venoms by direct infusion nano-electrospray ionization mass spectrometry: potential use in venom identification and taxonomy.
    Souza GH; Catharino RR; Ifa DR; Eberlin MN; Hyslop S
    J Mass Spectrom; 2008 May; 43(5):594-9. PubMed ID: 18200607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.